STANDARD BIOTOOLS INC. — Director's Dealing 2021

Feb 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2021-02-20

Reporting Person: McCracken Colin (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-20	Common Stock	M	2598	—	Acquired	22684	Direct
2021-02-20	Common Stock	M	1531	—	Acquired	24215	Direct
2021-02-20	Common Stock	M	9562	—	Acquired	33777	Direct
2021-02-20	Common Stock	F	7872	$6.12	Disposed	25905	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-20	Restricted Stock Units	$	M	2598	Disposed		Common Stock (2598.0)	Direct
2021-02-20	Restricted Stock Units	$	M	1531	Disposed		Common Stock (1531.0)	Direct
2021-02-20	Restricted Stock Units	$	M	9562	Disposed		Common Stock (9562.0)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

F2: On March 10, 2019, the Reporting Person was granted 41,564 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F3: On April 30, 2019, the Reporting Person was granted 24,500 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.